Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal


Suchbegriffe: CLOPIDOGREL - , . Treffer: 4


Tscharre, M; Egger, F; Machata, M; Rohla, M; Michael, N; Neumayr, M; Zweiker, R; Hajos, J; Adlbrecht, C; Suppan, M; Helmreich, W; Eber, B; Huber, K; Weiss, TW Contemporary use of P2Y12-inhibitors in patients with acute coronary syndrome undergoing percutaneous coronary intervention in Austria: A prospective, multi-centre registry.
PLoS One. 2017; 12(6):e0179349-e0179349 Doi: 10.1371/journal.pone.0179349 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG



Bedeir, K; Bliden, K; Tantry, U; Gurbel, PA; Mahla, E Timing of Coronary Bypass Surgery in Patients Receiving Clopidogrel: The Role of VerifyNow.
Can J Cardiol. 2016; 32(6):724-725 Doi: 10.1016/j.cjca.2016.01.038
Web of Science PubMed FullText FullText_MUG



Metzler, H; Prüller, F; Münch, A; Primus, G; Kainz, J; Hödl, R; Rehak, P Premature preoperative discontinuation of antiplatelet drug therapy in cardiovascular risk patients: a preliminary study on the role of P2Y12 receptor monitoring.
Eur J Anaesthesiol. 2010; 27(2):138-145 Doi: 10.1097/EJA.0b013e32832eb521 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar


Pelzmann, B; Zorn-Pauly, K; Hallström, S; Mächler, H; Jakubowski, A; Lang, P; Koidl, B Effects of thienopyridines and thienopyrimidinones on L-type calcium current in isolated cardiomyocytes.
Naunyn Schmiedebergs Arch Pharmacol. 2010; 382(5-6):433-440 Doi: 10.1007/s00210-010-0557-y
Web of Science PubMed FullText FullText_MUG


© Med Uni Graz Impressum